---
figid: PMC11806010__41541_2025_1084_Fig4_HTML
figtitle: Clec9a-initiated ITAM-Syk signaling cascade and downstream pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11806010
filename: 41541_2025_1084_Fig4_HTML.jpg
figlink: /pmc/articles/PMC11806010/figure/F4/
number: F4
caption: 'Upon binding to its ligand, Clec9a triggers the Syk-ITAM signaling pathway,
  which in turn potentially engages multiple downstream pathways, including the Raf-1,
  CARD9, NIK, MAPK, NF-κB, NFAT, and ROS-NLRP3-Caspase 1 pathways. Created with BioRender.com
  (Agreement number: YK26UDW783)'
papertitle: Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular
  insights and therapeutic potentials
reftext: Zubair Hussain, et al. NPJ Vaccines. 2025;10(NA).
year: '2025'
doi: 10.1038/s41541-025-01084-2
journal_title: NPJ Vaccines
journal_nlm_ta: NPJ Vaccines
publisher_name: Nature Publishing Group
keywords: Tumour immunology | Vaccines
automl_pathway: 0.9390325
figid_alias: PMC11806010__F4
figtype: Figure
redirect_from: /figures/PMC11806010__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11806010__41541_2025_1084_Fig4_HTML.html
  '@type': Dataset
  description: 'Upon binding to its ligand, Clec9a triggers the Syk-ITAM signaling
    pathway, which in turn potentially engages multiple downstream pathways, including
    the Raf-1, CARD9, NIK, MAPK, NF-κB, NFAT, and ROS-NLRP3-Caspase 1 pathways. Created
    with BioRender.com (Agreement number: YK26UDW783)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CARD9
  - BCL10
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - CLEC9A
  - SYK
  - RAF1
  - MAP3K14
  - MAP4K4
  - MALT1
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - NLRP3
  - RELB
  - NFKB1
---
